Not Tagged
Not Tagged
['pancsm']
dr thomas seufferlein of concludes that yes we should determine kras status (wt -10%) in #pancsm where clinical trial access can be determined for future targeted or combination therapy #gionc #asco22 
#FosterCare alum, #GIonc, #pallonc, and #survonc doc @ParkviewHealth.Uniting support and cancer care #supponc #hpm #hapc  Tweets are own.